Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T12:45:58.974Z.
Calculation as of: 2026-10-06T12:45:58.974Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: aa9bc7f9cefff507f8a4fe626b62717351a0ace1a98d881cea9fd3b4864bb5d1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Clover Health Investments, Corp.
Market Cap
$2.43B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.34B
EV/EBITDA Ratio
10.67x
TTM Avg
16.44x
3Y Avg
40.11x
5Y Avg
40.11x
Market Cap
$2.51B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.31B
EV/EBITDA Ratio
7.48x
TTM Avg
6.56x
3Y Avg
7.54x
5Y Avg
13.22x
Market Cap
$2.17B
EV/EBITDA Ratio
N/A
TTM Avg
238.50x
3Y Avg
123.46x
5Y Avg
123.46x
Market Cap
$2.69B
EV/EBITDA Ratio
9.50x
TTM Avg
8.14x
3Y Avg
8.61x
5Y Avg
8.66x
Market Cap
$2.69B
EV/EBITDA Ratio
13.24x
TTM Avg
11.53x
3Y Avg
20.03x
5Y Avg
19.21x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clover Health Investments, Corp. (CLOV) | $2.43B | N/A | N/A | N/A | N/A |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 10.67x | 16.44x | 40.11x | 40.11x |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | N/A | N/A | N/A | N/A |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.31B | 7.48x | 6.56x | 7.54x | 13.22x |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | N/A | N/A | N/A | N/A |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.64B | N/A | N/A | N/A | N/A |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.17B | N/A | 238.50x | 123.46x | 123.46x |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 9.50x | 8.14x | 8.61x | 8.66x |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 13.24x | 11.53x | 20.03x | 19.21x |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 12.84x | 13.80x | 16.03x | 17.55x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
